Cargando…
Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
Medical affairs has received a lot of attention in recent years in Japan, but it is also often misunderstood or poorly understood in the healthcare industry in Japan. In the United States, the function of medical affairs has been established for a long time, whereas its history in Japan is relativel...
Autor principal: | Maeda, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381039/ https://www.ncbi.nlm.nih.gov/pubmed/34434941 http://dx.doi.org/10.3389/fmed.2021.672095 |
Ejemplares similares
-
Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011) -
Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018) -
The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017) -
Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry
por: Jandhyala, Ravi
Publicado: (2022) -
Pharmaceutical company perspectives on current safety risk communications in Japan
por: Urushihara, Hisashi, et al.
Publicado: (2014)